Page last updated: 2024-11-08

pentylenetetrazole and Vascular Diseases

pentylenetetrazole has been researched along with Vascular Diseases in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamilton, JM1

Other Studies

1 other study available for pentylenetetrazole and Vascular Diseases

ArticleYear
The effect of metrazol on the pulmonary arteries of the cat.
    The Journal of pathology and bacteriology, 1966, Volume: 91, Issue:2

    Topics: Animals; Cats; Pentylenetetrazole; Pulmonary Artery; Vascular Diseases

1966